For blood cancers the two things that change outcomes are an accurate diagnosis and access to the right therapy at the right moment. The hospitals we name are in the highest tier of the Fudan ranking.
Acute and chronic leukaemias, including relapsed and refractory disease.
Hodgkin and non-Hodgkin lymphoma, including diffuse large B-cell lymphoma after multiple lines of treatment.
Relapsed myeloma, including BCMA-targeted CAR-T where the treating hospital considers it appropriate.
A haematopathologist who sees a rare subtype every month reads a bone marrow slide differently from one who sees it once a year. That is not a criticism of any individual doctor — it is simply what volume does.
It is one reason people seek a second opinion even if they treat at home. The written report is yours to take back to your own oncologist.
We read what you send and identify gaps.
Licensed haematologists review the case.
Options, costs and a timeline you can act on.
Only if you decide to go, and not before.
Tell us briefly what you need. If China is not the right answer, we will say so first.
Medical concierge · reply within 48 hours
A coordinator will read your enquiry and reply by email within 48 hours. Anything to add? Write to service@mosohealth.com.
